The discovery of the antiplatelet effect of aspirin: A personal reminiscence

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 9, 2003, Pages 1869-1875

  Weiss, H J ^a  

^a Surgeons and St Luke's Roosevelt Hospital Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; THROMBOCYTE FACTOR 3;

ARTICLE; BLEEDING TIME; HISTORY; HUMAN; PHYSIOLOGY; THROMBOSIS;

ASPIRIN; BLEEDING TIME; HISTORY, 20TH CENTURY; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET FACTOR 3; THROMBOSIS;

EID: 2442561675     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00433.x     Document Type: Article

References (38)

1. Alighieri D. Nel mezzo del cammin di nostra vita, mi ritrovai...La Divina Commedia c. 1310-1314; Canto I, lines 1-2.
2. Biggs R, Douglass AS. The thromboplastin generation test. J Clin Pathol 1953; 6: 23-9.
3. Weiss HJ, Eichelberger JW. The detection of platelet defects in patients with bleeding disorders-use of a quantitative assay for platelet factor 3. Am J Med 1962; 32: 872-83.
4. Hardisty RM, Hutton RA. The kaolin clotting time of platelet-rich plasma. A test of platelet factor 3 availability. Br J Haematol 1965; 11: 258-68.
5. Spaet TH, Cintron J. Studies on platelet factor 3 availability. Br J Haematol 1965; 11: 269-75.
6. Gaarder A, Jonsen J, Laland S, Hellem A. Adenosine diphosphate in red cells as factor in platelet adhesiveness. Nature 1961; 192: 531-2.
7. Weiss HJ. Platelet aggregation, adhesion and ADP release in thrombo-pathia (platelet factor 3 deficiency)-a comparison with Glanzmann's thrombasthenia and von Willebrand disease. Am J Med 1967; 43: 570-8.
8. Hovig T. Release of platelet aggregating substance (adenosine dipho sphate) from rabbit blood platelets induced by saline extract of tendons. Thromb Diath Haemorrh 1963; 19: 264-78.
9. Spaet T, Zucker M. Mechanism of platelet plug formation and role of adenosine diphosphate. Am J Physiol 1964; 206: 1267-74.
10. Hardisty RM, Hutton RA. Bleeding tendency associated with 'new' abnormality of platelet behavior. Lancet 1967; 1: 983-5.
11. Quick AJ. Salicylates and bleeding: the aspirin tolerance test. Am J Med Sci 1967; 252: 265-9.
12. Beaumont JL, Willie A. Influence sur l'hémostase, de l'hypertension artérielle, des antivitamines K, de l'héparine et de l'acide acétyl salicylique. Sang 1955; 26: 880-91.
13. Blatrix C. Allongement du temps de saignement sous l'influence de certain medicaments. Nouv Rev Franc Hemat 1963; 3: 346-50.
14. Weiss HJ, Aledort LM. Impaired platelet-connective tissue reaction in man after aspirin ingestion. Lancet 1967; 2: 495-7.
15. Weiss HJ. Aspirin ingestion compared with bleeding disorders-search for a useful platelet antiaggregant. Blood 1970; 35: 333-40.
16. Mustard JF, Glynn MF, Nishizawa EE, Packham MA. Platelet surface interactions: relationship to thrombosis and hemostasis. Federation Proc 1967; 26: 106-14.
17. Packham MA, Warrior ES, Glynn MF, Senyi AS, Mustard JF. Alteration of the response of platelets to surface stimuli by pyrazole compounds. J Exp Med 1967; 126: 171-88.
18. Evans G, Packham MA, Nishizawa EE, Mustard JF, Murphy EA. The effect of acetylsalicylic acid on platelet function. J Exp Med 1968; 128: 877-94.
19. Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest 1968; 47: 2169-80.
20. Zucker MB, Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med 1968; 127: 547-51.
21. O'Brien J. Effect of salicylates on human platelets. Lancet 1968; i: 779-83.
22. al-Mondhiry H, Marcus AJ, Spaet TH. On the mechanism of platelet function inhibition by acetylsalicylic acid. Proc Soc Exp Biol Med 1970; 133: 632-6.
23. Danese CA, Voleti CD, Weiss HJ. Protection by aspirin against experi mentally induced arterial thrombosis in dogs. Thromb Diath Haemorrh 1971; 25: 288-96.
24. Weiss HJ, Tschopp TB, Baumgartner HR. Impaired interaction (adhe sion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion-a comparison with von Willebrand disease. N EnglJ Med 1975; 293: 619-723.
25. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971; 231: 232-5.
26. Smith JB, Willis AL. Aspirin selectively inhibits prostaglandin produc tion in human platelets. Nature 1971; 231: 235-7.
27. Willis AL, Kuhn DC. A new potential mediator of arterial thrombosis whose biosynthesis is inhibited by aspirin. Prostaglandins 1973; 4: 127-9.
28. Hamberg M, Svensson J, Wakabayski T, Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet ag gregation. Proc NatlAcad Sci USA 197 4; 71: 345-9.
29. Hamberg M, Samuelsson B. Prostaglandin endoperoxides-novel trans formations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 1974; 71: 3400-4.
30. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperox ides. Proc Natl Acad Sci USA 1975; 72: 2994-8.
31. Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets I. Acetylation of a particulate fraction protein. J Clin Invest 1975; 56: 624-32.
32. Weiss HJ. Antiplatelet therapy. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligssohn U, eds. Williams Hematology, 6th edn. New York: McGraw-Hill, 2001: 1763-76.
33. Weiss HJ, Lages B. The response of platelets to epinephrine in storage pool deficiency-evidence pertaining to the role of ADP in mediating primary and secondary aggregation. Blood 1988; 72: 1717-25.
34. Craven LL. Experiences with aspirin (acetylsalicylic acid) in the non specific prophylaxis of coronary thrombosis. Mississippi Valley Med J 1953; 75: 38-44.
35. Weiss HJ. The pharmacology of platelet inhibition. In: Spaet TH, ed. Progress in Hemostasis and Thrombosis. New York: Grune & Stratton, 1972; 1: 199-231.
36. Weiss HJ. Scott syndrome: a disorder of platelet coagulant activity (PCA). Sem Hemat 1994; 31: 312-9.
37. Weiss HJ, Turitto VT, Baumgartner HR. The role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium: studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest 1986; 78: 1072-82.
38. Pope A. An Essay on Man. 1733; Epistle II, line 2.